Susan Schneider - Aug 21, 2022 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP (AGTC)

Role
Chief Medical Officer
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Stock symbol
AGTC
Transactions as of
Aug 21, 2022
Transactions value $
$0
Form type
4
Date filed
8/24/2022, 08:07 PM
Previous filing
Nov 16, 2021
Next filing
Dec 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (right to buy) Award $0 +142K $0.00 142K Aug 21, 2022 Common Stock 142K $0.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in equal monthly installments over four years from the date of grant.